Inventor
REMEN LUBOS
CH14 patents
⚠️ This page may combine multiple inventors who share the name “REMEN LUBOS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDORSIA PHARMACEUTICALS LTD
7 patentsUS12410208B2Sep 9, 2025
(2-acetamidyl)thio-beta-D-galactopyranoside derivatives
IDORSIA PHARMACEUTICALS LTD0 citations50
US12404295B2Sep 2, 2025
(Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives
IDORSIA PHARMACEUTICALS LTD0 citations50
US12319672B2Jun 3, 2025
Alpha-D-galactopyranoside derivatives
IDORSIA PHARMACEUTICALS LTD0 citations49
US12312362B2May 27, 2025
Spiro derivatives of Alpha-D-galactopyranosides
IDORSIA PHARMACEUTICALS LTD0 citations49
US12304902B2May 20, 2025
Hydroxyheterocycloalkane-carbamoyl derivatives
IDORSIA PHARMACEUTICALS LTD0 citations49
US12291519B2May 6, 2025
2-hydroxycycloalkane-1-carbamoyl
IDORSIA PHARMACEUTICALS LTD0 citations49
US12291520B2May 6, 2025
Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives
IDORSIA PHARMACEUTICALS LTD0 citations49
ACTELION PHARMACEUTICALS LTD
6 patentsUS7915259B2Mar 29, 2011
Diazabicyclononene derivatives and use thereof
ACTELION PHARMACEUTICALS LTD3 citations62
US7427613B2Sep 23, 2008
7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
ACTELION PHARMACEUTICALS LTD6 citations60
US7799805B2Sep 21, 2010
Piperidine carboxylic acid amide derivatives
ACTELION PHARMACEUTICALS LTD1 citations51
US7968720B2Jun 28, 2011
Secondary amines as renin inhibitors
ACTELION PHARMACEUTICALS LTD0 citations41
US10189839B2Jan 29, 2019
Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase
ACTELION PHARMACEUTICALS LTD0 citations37
US9765092B2Sep 19, 2017
Tricyclic piperidine compounds
ACTELION PHARMACEUTICALS LTD0 citations37